Our Leaders

Kent Thoelke was named Senior Vice President and Head of Scientific & Medical Affairs in June 2006. Mr. Thoelke provides scientific and strategic oversight of product development to empower project teams and promote the success of drugs in development on behalf of our clients.

Prior to joining PRA, Mr. Thoelke was Executive Director of Corporate Development and held various Director-level roles for Pharmaceutical Product Development, Inc. (PPD). Under his leadership, the company successfully expanded its global therapeutic/strategic development program across all major therapeutic areas.

Mr. Thoelke has over 19 years of experience in all aspects of the global drug development and device industry with particular expertise in the execution of all aspects of global oncology studies. Having visited over 40 countries, he is familiar with the global drug development environment, and has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and its effect on drug development timelines. He is active in pursuing novel technologies and strategies to move the current clinical drug development paradigm towards a more focused evidence-based strategy.